Featured Press Releases

SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine

SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine

OncoIncytes Launched by 1Cell.Ai (Previously OneCell Diagnostics) to Integrate Multi-Modal Data for Precision Oncology

OncoIncytes Launched by 1Cell.Ai (Previously OneCell Diagnostics) to Integrate Multi-Modal Data for Precision Oncology

  • 22 Apr 2025

OneCell Diagnostics announced its launch of OncoIncytes, a comprehensive multi-modal cancer...

Marius Pharmaceuticals has expanded its global footprint with Health Canada’s approval of KYZATREX® (testosterone undecanoate) CIII capsules

Marius Pharmaceuticals has expanded its global footprint with Health Canada’s approval of KYZATREX® (testosterone undecanoate) CIII capsules

Element Science Receives FDA Approval for the Revolutionary Jewel® Patch Wearable Cardioverter Defibrillator

Element Science Receives FDA Approval for the Revolutionary Jewel® Patch Wearable Cardioverter Defibrillator

Data on BIMZELX® (bimekizumab-bkzx) in Hidradenitis Suppurativa Showed Sustained Improvements in Pain and Draining Tunnel Resolution for Three Years

Data on BIMZELX® (bimekizumab-bkzx) in Hidradenitis Suppurativa Showed Sustained Improvements in Pain and Draining Tunnel Resolution for Three Years

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

SUANNUTRA USA secures U.S. distribution rights for TetraSOD.

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

  • Medella Springs
  • 02 Jun 2026
Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

  • Seegene
  • 02 Jun 2026
Greater Stability and Control for Everyday Injections: Ascensia Diabetes Care Expands the CONTOUR® Portfolio with CONTOUR® COMFORT Pen Needles

Greater Stability and Control for Everyday Injections: Ascensia Diabetes Care Expands the CONTOUR® Portfolio with CONTOUR® COMFORT Pen Needles

  • Ascensia Diabetes Care
  • 02 Jun 2026
XOCOVA® Becomes First Oral Option for Post-Exposure COVID-19 Prevention

XOCOVA® Becomes First Oral Option for Post-Exposure COVID-19 Prevention

  • Shionogi USA
  • 01 Jun 2026
EU Approves Expanded Label for Opdivo® + AVD in Advanced Hodgkin Lymphoma

EU Approves Expanded Label for Opdivo® + AVD in Advanced Hodgkin Lymphoma

  • Bristol Myers Squibb
  • 01 Jun 2026
FoundationOne® Diagnostics Approved for TALZENNA®–XTANDI® Therapy

FoundationOne® Diagnostics Approved for TALZENNA®–XTANDI® Therapy

  • Foundation Medicine
  • 01 Jun 2026
The Digital Pharma Advances Conference 2026

Most Popular
June   2026
M T W T F S S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30          

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.